Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Feasibility of Managing Cancer and Living Meaningfully (CALM) in Addressing Traumatic Stress Among Individuals with Newly Diagnosed and Recurrent Ovarian Cancer: A Phase II Trial

FY 2023-24

Summary
Ovarian cancer (OC) ranks seventh in common global cancer diagnoses and eighth in fatality rate. The absence of early screening and asymptomatic presentation contribute to delayed diagnoses, recurrence after treatment, and poor prognosis. Survival rates are below 50%, with a threefold higher case-to-fatality ratio than breast cancer and surgical interventions may exacerbate distress. Despite evidence supporting the effectiveness of psychotherapeutic interventions, such support is not standard for OC patients. Managing Cancer and Living Meaningfully (CALM) is a brief, tailored psychotherapeutic intervention for patients with advanced cancer, addressing medical decisions, relationships, life meaning, and future plans. CALM has been shown efficacy in alleviating depression and death anxiety, and in improving communication and clarification of goals in patients with advanced cancer. I aim to conduct a multi-method, single-arm, phase II trial of the feasibility, acceptability and preliminary effectiveness of CALM following a new diagnosis or recurrence of OC, with traumatic stress symptoms as the primary outcome, as this outcome has never been evaluated before. Secondary outcomes include depression, death anxiety and perceived benefit of CALM, assessed with validated questionnaires. Participants from Princess Margaret Cancer Centre's Ovarian Cancer Clinic will be recruited to this study. The findings from this study will offer insights into the benefits of early delivery of psychotherapeutic interventions to alleviate the traumatic stress symptoms emerging from a diagnosis or recurrence of life-limiting cancers. Data from the proposed study can serve to inform a large randomized controlled trial of the effectiveness of CALM among newly diagnosed and recurred OC patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506056
Name
George Megan A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Feasibility of Managing Cancer and Living Meaningfully (CALM) in Addressing Traumatic Stress Among Individuals with Newly Diagnosed and Recurrent Ovarian Cancer: A Phase II Trial
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Stress Disorder; Cancer; Oncology; Ovarian; Palliative; Posttraumatic Stress Disorder; Psychosocial; Psychotherapy; Traumatic Stress
Abstract
Ovarian cancer (OC) ranks seventh in common global cancer diagnoses and eighth in fatality rate. The absence of early screening and asymptomatic presentation contribute to delayed diagnoses, recurrence after treatment, and poor prognosis. Survival rates are below 50%, with a threefold higher case-to-fatality ratio than breast cancer and surgical interventions may exacerbate distress. Despite evidence supporting the effectiveness of psychotherapeutic interventions, such support is not standard for OC patients. Managing Cancer and Living Meaningfully (CALM) is a brief, tailored psychotherapeutic intervention for patients with advanced cancer, addressing medical decisions, relationships, life meaning, and future plans. CALM has been shown efficacy in alleviating depression and death anxiety, and in improving communication and clarification of goals in patients with advanced cancer. I aim to conduct a multi-method, single-arm, phase II trial of the feasibility, acceptability and preliminary effectiveness of CALM following a new diagnosis or recurrence of OC, with traumatic stress symptoms as the primary outcome, as this outcome has never been evaluated before. Secondary outcomes include depression, death anxiety and perceived benefit of CALM, assessed with validated questionnaires. Participants from Princess Margaret Cancer Centre's Ovarian Cancer Clinic will be recruited to this study. The findings from this study will offer insights into the benefits of early delivery of psychotherapeutic interventions to alleviate the traumatic stress symptoms emerging from a diagnosis or recurrence of life-limiting cancers. Data from the proposed study can serve to inform a large randomized controlled trial of the effectiveness of CALM among newly diagnosed and recurred OC patients.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
George, Megan A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~